Phase II randomised, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis
Sign up to keep reading
Create a free Member account at NZ Optics to read this article and more.
- Read all Member articles
- Full digital magazine archive
- Early access to new articles







